Fund Companies Rights Offerings Managed Distributions Leveraged Funds IPOs Asset Classes CEF Advisors

My Fund Comparison
Initilizing list...

H&Q Healthcare Investors and H&Q Life Sciences Investors Announce Investor Information Seminar
H&Q Healthcare Investors

BOSTON, Jun 07, 2012 (BUSINESS WIRE) -- H&Q Healthcare Investors and H&Q Life Sciences Investors invite you to attend or participate via webcast an Investor Information Seminar on Wednesday, June 13, 2012, at 9:00 a.m. The Seminar will be held at the Downtown Club of Boston, 38th Floor, Boston, Massachusetts.

The Investor Information Seminar will include:

Comments by the Portfolio Manager Presentations by Portfolio Companies Panel Discussion: Healthcare Reform Key Note Speaker: Michael W. Bonney

Please RSVP to or obtain webcast information at www.hqcm.com or (617) 772-8500.

H&Q Healthcare Investors HQH +0.06% is a closed-end fund that invests in public and private companies in the healthcare industry. Hambrecht & Quist Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.

H&Q Life Sciences Investors HQL +0.73% is a closed-end fund that invests in public and private companies in the life sciences industry. Hambrecht & Quist Capital Management LLC, based in Boston, serves as Investment Adviser to the Fund. Shares of the Fund can be purchased on the New York Stock Exchange through any securities broker.


Image Map

Resources

Aberdeen Webcasts

Aberdeen Closed-End TV

CEF Connect

Bonds

National Association of
Publicly Traded Partnerships


REITs


SySys Logo

Lipper Logo
Powered by a SySys data & content management system.

©Thomson Reuters 2011. All rights reserved. Any copying, republication or redistribution of Lipper, a Thomson Reuters company, content, including by caching, framing or similar means, is expressly prohibited without the prior written consent of Lipper, a Thomson Reuters company. Lipper, a Thomson Reuters company shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.